Hemorrhage clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

    open to eligible people ages 18-90

    The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.

    San Francisco, California and other locations

Our lead scientists for Hemorrhage research studies include .

Last updated: